Cilcare

Cilcare company information, Employees & Contact Information

Explore related pages

Related company profiles:

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.

Company Details

Employees
59
Founded
-
Address
378 Rue Du Professeur Joseph-Blayac, Montpellier,languedoc-Roussillon 34080,france
Phone
+33 (0)7 81 34 16 31
Email
in****@****are.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Montpellier, Languedoc-Roussillon
Looking for a particular Cilcare employee's phone or email?

Cilcare Questions

News

Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE - PR Newswire

Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE PR Newswire

Shionogi inks new hearing loss research deal with Cilcare - The Pharma Letter

Shionogi inks new hearing loss research deal with Cilcare The Pharma Letter

Cilcare Secures Funding to Advance Clinical Trials for Cochlear Synaptopathy Treatment - The Hearing Review

Cilcare Secures Funding to Advance Clinical Trials for Cochlear Synaptopathy Treatment The Hearing Review

France Awards Cilcare Funding to Combat Hidden Hearing Loss - The Hearing Review

France Awards Cilcare Funding to Combat Hidden Hearing Loss The Hearing Review

Cilcare and Shionogi Announce Option Agreement for Hearing Disorder Treatment - The Hearing Review

Cilcare and Shionogi Announce Option Agreement for Hearing Disorder Treatment The Hearing Review

Cilcare Names New Chief Medical Officer - The Hearing Review

Cilcare Names New Chief Medical Officer The Hearing Review

CILcare Welcomes Experts in Auditory Science - The Hearing Review

CILcare Welcomes Experts in Auditory Science The Hearing Review

CILcare Initiates Second Phase of Tinnitus Research Project DETECT - The Hearing Review

CILcare Initiates Second Phase of Tinnitus Research Project DETECT The Hearing Review

Top Cilcare Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant